β-defensin 1 Inhibitors
The class of chemicals known as β-defensin 1 Inhibitors includes compounds that potentially interfere with the expression or activity of β-defensin 1 indirectly. These chemicals, primarily immunosuppressive or anti-inflammatory agents, might reduce the expression of β-defensin 1 as part of their broader effects on the immune system.
Corticosteroids, such as Hydrocortisone, and other immunosuppressants like Cyclosporine A and Tacrolimus, work by broadly suppressing the immune response, which could potentially lead to decreased β-defensin 1 expression. Drugs like Azathioprine, Methotrexate, and Tofacitinib, used in autoimmune and inflammatory conditions, might also indirectly inhibit β-defensin 1 due to their effects on immune modulation. Biologics like Infliximab and Rituximab, which target specific components of the immune system (such as TNF-α and CD20, respectively), could also impact β-defensin 1 expression indirectly. Other drugs, such as Thalidomide and Sulfasalazine, known for their immunomodulatory and anti-inflammatory properties, might similarly lead to a reduction in β-defensin 1 expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that could potentially decrease the expression of β-defensin 1 by inhibiting T-cell activation and related immune responses. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Another immunosuppressant that may inhibit T-cell activation, potentially leading to decreased expression of β-defensin 1. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
As an immunosuppressive drug, it could potentially impact the expression of immune-related proteins, including β-defensin 1. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Used for autoimmune diseases, it might indirectly inhibit β-defensin 1 expression through its immunosuppressive effects. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $37.00 $109.00 | 1 | |
An immunosuppressant that could indirectly reduce the expression of β-defensin 1 through its effects on lymphocyte proliferation. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
A corticosteroid that can suppress immune function, potentially leading to decreased β-defensin 1 expression. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Known for its immunomodulatory effects, it might indirectly reduce β-defensin 1 expression by altering immune responses. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Used in inflammatory bowel disease, could potentially reduce β-defensin 1 expression through its anti-inflammatory effects. | ||||||